Shahnawaz Notta DO: Resident Physician Research Profile and Publications (2026)

While compiling a literature list on cardiac medications, the same name appeared repeatedly across papers on different topics.

My first reaction wasn't "Who is this person?" but "Are these papers really by the same author?"

So I did something routine: I went through his public academic profile from start to finish, grouped the topics, and then checked whether the institution and title were consistent.

This article is the result of that verification.

If you also came across the name Shahnawaz Notta in a paper, a research forum list, or a citation in a case discussion, this can provide a more efficient starting point.

Why Are You Searching for This Name? Three Common Scenarios

First, you're reading a paper and want to confirm the author's research background and areas of expertise.

Second, you're peer reviewing, writing a literature review, or preparing a presentation, and need to decide whether this name is worth following up on.

Third, you're just cross-checking a list and want to know which institution and department this name corresponds to.

The information needed for these three scenarios is actually different, but the starting point is the same: first confirm "who this name represents," then discuss everything else.

What Public Records Show: Title, Institution, and Research Outline

According to currently available public academic profiles, Shahnawaz Notta's current position is listed as Resident Physician in the Department of Internal Medicine at East Tennessee State University (ETSU) Quillen College of Medicine, located in Johnson City, Tennessee.

The DO after his name stands for Doctor of Osteopathic Medicine, a medical degree in the United States.

This point is worth clarifying upfront: in the U.S., DO and MD are two parallel paths of physician training. After completing the degree, both enter residency training and can pursue specialties such as internal medicine and cardiology.

Seeing DO doesn't require any other interpretation.

On his ResearchGate profile, the research expertise fields listed are internal medicine, clinical cardiology, infectious diseases, and redox signaling and redox biology.

The search summary on the same profile shows approximately 94 publications and 42 citations.

I treat these two numbers as "volume references," not evaluations.

The reason: publication counts on profiles typically include conference abstracts, posters, case reports, and journal articles all together; citation counts change daily.

His Research Map as Seen from Public Publications

After grouping by topic, the outline is quite clear: one major area is clinical cardiology, another is database analyses related to gastroenterology and oncology, plus infectious diseases and basic models.

Cardiac Medications and Side Effects

One clear main line is the antiarrhythmic drug amiodarone.

The research description in public records mentions that amiodarone is an iodine-containing antiarrhythmic drug commonly used to treat ventricular and supraventricular arrhythmias; although its clinical efficacy is clear, because it is lipophilic and tends to accumulate in multiple organs, its side effect profile is relatively complex.

The characteristic of this type of topic is that it doesn't look at how unique a single case is, but at how risks are distributed with long-term use.

For readers, this means related content is usually suitable for discussions of "medication safety" and "long-term follow-up," rather than acute management.

The Choice in Cardiovascular Imaging

Another publicly visible publication addresses the trade-offs between CT and MRI in diagnosing coronary artery disease, with the title focused on "precision."

Co-authors include Priyanka Vatsavayi, Hezborn Magacha, Sagar Nagpal, Sean Moore, Sabahuddin Hajjar, and others.

The value of this type of review topic usually lies in clarifying "which imaging modality to choose under what circumstances," rather than declaring one test universally superior.

Healthcare Utilization and Economic Burden of Pancreatic Cancer

At the 2024 ETSU Appalachian Student Research Forum, there was a study analyzing healthcare utilization and comorbidity burden of pancreatic cancer hospitalizations using a U.S. national sample database, with authors including Shahnawaz Notta, Sanku Koushik, Venkata Vedantam, Sudeepthi Mekala, Mark Young, and others.

The abstract cites 2023 American Cancer Society data stating that pancreatic cancer accounts for about 3% of all cancer diagnoses in the U.S. and is among the leading causes of cancer-related death, with a five-year survival rate of approximately 5% to 15%.

The study aims to assess the economic burden of pancreatic cancer in diagnosis, treatment, and management, as well as the financial impact on patients, the healthcare system, and society overall.

Note that the page indicates the document is currently unavailable, so only abstract-level information is visible.

Infectious Diseases and Rare Cases

There is also a case report on disseminated histoplasmosis presenting like hemophagocytic lymphohistiocytosis (HLH), reminding that the two can be confused.

The public abstract mentions that the calculated H-score for the case was 193, corresponding to an approximately 80% to 88% probability of hemophagocytic syndrome, and a bone marrow biopsy was subsequently arranged to rule out HLH.

Co-authors include Mohannad Al Akeel, Arjun Natarajan, Ameera Eftaiha, Michael Cartwright, and Kanishka Chakraborty, from the departments of internal medicine, pathology, and oncology, respectively.

The reading focus of such case reports is never "rare," but "when should it be included in the differential diagnosis."

Basic and In Vitro Models

There is also a more basic-oriented direction: a July 2023 study on an in vitro stretch and strain model, using the Mechanoculture FX device to simulate the effects of myofascial release on adipose stem cells, and observing the response of these stem cells when co-cultured with pancreatic and prostate cancer cells.

This line seems far from the previous clinical topics, but if you want to understand the full profile of a researcher, this kind of breadth is actually an important clue.

How I Read a ResearchGate Profile: Four Verification Steps

Here I break down my own approach, which you can follow directly.

Step 1: Confirm Institution and Department First

Open the profile and look first at Current institution and Current position, not the publication count.

If the institution doesn't match, there's no point in going further.

Step 2: Identify the Co-author Network

If the same name appears in different papers with highly overlapping co-author groups and consistent institutions, it can generally be confirmed as the same person.

If the co-authors are completely different and the departments vary widely, be more cautious.

Step 3: Group by Topic, Not by Date

Sorting by date only shows you a list of titles.

Grouping by topic reveals "what problems this person repeatedly addresses."

Step 4: Go Back and Confirm the Publication Type of Each Item

Journal articles, conference abstracts, posters, and case reports differ in weight and citability.

When organizing, I label each item with its type to avoid citing conference abstracts as peer-reviewed papers.

Three Things to Note Before Citing This Name

First, name confusion is more common than you think.

The surname Notta is not particularly rare in academic databases, and authors with the same name or similar spelling may appear.

Always cross-check using institution, department, and co-authors.

Second, profile numbers change.

Publication and citation counts are live statistics; what you see when you screenshot may differ from what readers see.

When writing for formal documents, it's advisable to use phrasing like "according to public academic profiles."

Third, conference abstracts are not full papers.

As with the student research forum mentioned earlier, the page may only disclose the abstract or even indicate the document is not yet available.

Be clear about the level when citing—this is basic respect for readers.

Additionally, if you plan to use such research content in clinical discussions or patient education materials, please rely on the original papers and current clinical guidelines; public profile abstracts are insufficient to support medical decisions.

Three Benefits of This Method

• You won't mistakenly merge papers by different people into one author's profile.
• You can articulate "what this person mainly researches" in minutes, rather than just reciting a title.
• You'll naturally include publication type and source when citing, raising the credibility of your document by a level.

Quick Start Checklist

1. Open the public academic profile and read the Current institution and Current position fields first.
2. Note the research expertise fields as keywords for later categorization.
3. List all publication titles and group them by topic, not year.
4. Identify recurring co-authors and build a name-institution cross-reference table.
5. Label each item's publication type: journal article, conference abstract, poster, case report.
6. When writing notes, consistently use "according to public records" phrasing and include original links.

A small trick I often use: write the verification process as a three-line note and save it in my own database.

Next time you encounter the same name, you don't need to rerun the process—just open the note to confirm.

There are no shortcuts to data verification, but there are methods.

Once you standardize the process, you'll find your speed in assessing unfamiliar names is much faster than you imagined.

Test it step by step, and you'll gradually master this verification method.

(This article is compiled from search results of public ResearchGate profiles and ETSU Digital Commons public pages. Information may be updated over time; please refer to the original pages and papers before formal citation.)

References

• Shahnawaz NOTTA | Resident Physician | Doctor of Osteopathic Medicine | East Tennessee State University, Johnson City | ETSU | Department of Internal Medicine | Research profile
• Digital Commons @ East Tennessee State University - Appalachian Student Research Forum: Healthcare Utilization and Comorbidity Burden of Pancreatic Cancer in U.S Hospitals. Analysis of a National Sample Database
• (PDF) Unveiling the Coronary Mystery: CT vs. MRI - Pioneering Precision in CAD Diagnosis
• (PDF) Development of an In-Vitro Stretch and Strain Model with Mechanoculture FX Device to Simulate the effects of Myofascial Release on Adipose Stem Cells and their response when co-cultured with pancreatic and prostate cancer cells.
• (PDF) Introduction Case Presentation Conclusion A Rare Case of Disseminated Histoplasmosis Masquerading as Hemophagocytic Lymphohistiocytosis: A Case Report